BDBM50256751 CHEMBL514670::N-(6-amino-5-chloropyridin-3-yl)-2-methyl-5-(3-(trifluoromethyl)benzamido)benzamide
SMILES: Cc1ccc(NC(=O)c2cccc(c2)C(F)(F)F)cc1C(=O)Nc1cnc(N)c(Cl)c1
InChI Key: InChIKey=BYCBVTAUYYXCCF-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cytochrome P450 2C9 (Homo sapiens (Human)) | BDBM50256751 (CHEMBL514670 | N-(6-amino-5-chloropyridin-3-yl)-2-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 1.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Boston Curated by ChEMBL | Assay Description Inhibition of CYP2C9 (unknown origin) | Bioorg Med Chem Lett 19: 1026-9 (2009) Article DOI: 10.1016/j.bmcl.2008.10.053 BindingDB Entry DOI: 10.7270/Q2222TMP | |||||||||||
More data for this Ligand-Target Pair |